Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects

Guofei LiDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China, [email protected]

Mingming ZhaoDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China, [email protected]

Feng QiuDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China, [email protected]

Yaxin SunDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China, [email protected]

Limei ZhaoDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China, [email protected]Correspondence[email protected]

Pages 129-139 | Published online: 20 Dec 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

ZhouXZhangWLiuXZhangWLiYInterrelationship between diabetes and periodontitis: role of hyperlipidemiaArch Oral Biol201560466767425443979
PubMed Web of Science ®Google Scholar
ChungSDWangKHTsaiMCLinHCChenCHHyperlipidemia is associated with chronic urticaria: a population-based studyPLoS One2016113e0150304e015030926964045
PubMed Web of Science ®Google Scholar
Maged AminMRushdyMHyperlipidemia in association with pro-inflammatory cytokines among chronic spontaneous urticaria: case-control studyEur Ann Allergy Clin Immunol201850625426130066998
PubMed Web of Science ®Google Scholar
Hylton GravattLAFlurieRWLajthiaEDixonDLClinical guidance for managing statin and antimicrobial drug-drug interactionsCurr Atheroscler Rep201719114628990114
PubMed Web of Science ®Google Scholar
Abd El AalHAAhmedLAHassanWAFawzyHMMoawadHCombination of carvacrol with simvastatin improves the lipid-lowering efficacy and alleviates simvastatin side effectsJ Biochem Mol Toxicol20173112e21981
Web of Science ®Google Scholar
ShinnakasuAYamamotoKKuranoMThe combination therapy of fenofibrate and ezetimibe improved lipid profile and vascular function compared with statins in patients with Type 2 diabetesJ Atheroscler Thromb201724773574828450679
PubMed Web of Science ®Google Scholar
TarantinoNSantoroFde GennaroLFenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapyVasc Health Risk Manag201713294128243111
PubMed Web of Science ®Google Scholar
LiYJHuXBLuXLNanoemulsion-based delivery system for enhanced oral bioavailability and caco-2 cell monolayers permeability of berberine hydrochlorideDrug Deliv20172411868187329191058
PubMed Web of Science ®Google Scholar
FuKLvXLiWBerberine hydrochloride attenuates lipopoly-saccharide-induced endometritis in mice by suppressing activation of NF-κB signal pathwayInt Immunopharmacol201524112813225479718
PubMed Web of Science ®Google Scholar
LiDZhengJHuYAmelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in ratsPharmacogn Mag2017135267768229200733
PubMed Web of Science ®Google Scholar
LiGYangFLiuMSuXZhaoMZhaoLDevelopment and application of a UPLC-MS/MS method for simultaneous determination of fenofibric acid and berberine in rat plasma: application to the drug-drug pharmacokinetic interaction study of fenofibrate combined with berberine after oral administration in ratsBiomed Chromatogr20163071075108226577601
PubMed Web of Science ®Google Scholar
IshiiYItoYMatsukiSClinical drug-drug interaction potential of BFE1224, prodrug of antifungal ravuconazole, using two types of cocktails in healthy subjectsClin Transl Sci201811547748629768713
PubMed Web of Science ®Google Scholar
PoórMBodaGMohosVPharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albuminBiomed Pharmacother201810291292129710546
PubMed Web of Science ®Google Scholar
LiYLiuLWangXIn Vivo assessment of the effect of CYP1A2 inhibition and induction on pomalidomide pharmacokinetics in healthy subjectsJ Clin Pharmacol201858101295130429762875
PubMed Web of Science ®Google Scholar
QiuWJiangXHLiuCXJuYJinJXEffect of berberine on the pharmacokinetics of substrates of CYP3A and P-gpPhytother Res200923111553155819370549
PubMed Web of Science ®Google Scholar
WangYZhangYXiaoJXuRWangQWangXSimultaneous determination of baicalin, baicalein, wogonoside, wogonin, scutellarin, berberine, coptisine, ginsenoside Rb1 and ginsenoside Re of Banxia xiexin decoction in rat plasma by LC-MS/MS and its application to a pharmacokinetic studyBiomed Chromatogr2018
Web of Science ®Google Scholar
FollmanKEDaveRAMorrisMEEffects of renal impairment on transporter-mediated renal reabsorption of drugs and renal drug-drug interactions: a simulation-based studyBiopharm Drug Dispos201839421823129635775
PubMed Web of Science ®Google Scholar
MinJSBaeSKPrediction of drug-drug interaction potential using physiologically based pharmacokinetic modelingArch Pharm Res201740121356137929079968
PubMed Web of Science ®Google Scholar
LeeSCAryaVYangXVolpeDAZhangLEvaluation of transporters in drug development: Current status and contemporary issuesAdv Drug Deliv Rev201711610011828760687
PubMed Web of Science ®Google Scholar
YaoJKongWJiangJLearning from berberine: treating chronic diseases through multiple targetsSci China Life Sci201558985485924174332
PubMed Web of Science ®Google Scholar
MotawiTKTelebZAEl-BoghdadyNAIbrahimSAEffect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro studyJ Physiol Biochem201470122523724264056
PubMed Web of Science ®Google Scholar
TojcicJBenoit-BiancamanoMOCourtMHStrakaRJCaronPGuillemetteCIn vitro glucuronidation of fenofibric acid by human UDP-glucuronosyltransferases and liver microsomesDrug Metab Dispos200937112236224319661212
PubMed Web of Science ®Google Scholar
AsavapanumasNKittayaruksakulSMeetamPMuanprasatCChatsudthipongVSoodvilaiSFenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathwaysDrug Metab Pharmacokinet201227551351922473497
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date